Cited by 3,157Cardiac pacing and defibrillation studiesCardiac Arrest and ResuscitationCardiac Health and Mental Health

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Moss, Arthur J., Hall, W. Jackson, Cannom, David S., Klein, Helmut, Brown, Mary W., Daubert, James P., Estes, N.A. Mark, Foster, Elyse, Greenberg, Henry, Higgins, Steven L., Pfeffer, Marc A., Solomon, Scott D., Wilber, David, Zareba, Wojciech·2009·New England Journal of Medicine

DOI 10.1056/nejmoa0906431

Open this paper in CoChat — free account

Abstract

BACKGROUND: This trial was designed to determine whether cardiac-resynchronization therapy (CRT) with biventricular pacing would reduce the risk of death or heart-failure events in patients with mild cardiac symptoms, a reduced ejection fraction, and a wide QRS complex. METHODS: During a 4.5-year period, we enrolled and followed 1820 patients with ischemic or nonischemic cardiomyopathy, an ejection fraction of 30% or less, a QRS duration of 130 msec or more, and New York Heart Association class I or II symptoms. Patients were randomly assigned in a 3:2 ratio to receive CRT plus an implantable cardioverter-defibrillator (ICD) (1089 patients) or an ICD alone (731 patients). The primary end point was death from any cause or a nonfatal heart-failure event (whichever came first). Heart-failure events were diagnosed by physicians who were aware of the treatment assignments, but they were adjudicated by a committee that was unaware of assignments. RESULTS: During an average follow-up of 2.4 years, the primary end point occurred in 187 of 1089 patients in the CRT-ICD group (17.2%) and 185 of 731 patients in the ICD-only group (25.3%) (hazard ratio in the CRT-ICD group, 0.66; 95% confidence interval [CI], 0.52 to 0.84; P=0.001). The benefit did not differ significantly between patients with ischemic cardiomyopathy and those with nonischemic cardiomyopathy. The superiority of CRT was driven by a 41% reduction in the risk of heart-failure events, a finding that was evident primarily in a prespecified subgroup of patients with a QRS duration of 150 msec or more. CRT was associated with a significant reduction in left ventricular volumes and improvement in the ejection fraction. There was no significant difference between the two groups in the overall risk of death, with a 3% annual mortality rate in each treatment group. Serious adverse events were infrequent in the two groups. CONCLUSIONS: CRT combined with ICD decreased the risk of heart-failure events in relatively asymptomatic patients with a low ejection fraction and wide QRS complex. (ClinicalTrials.gov number, NCT00180271.)

Integrity signals

Registry

Crossref · 10.1056/nejmoa0906431

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Self-citation
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Self-citation
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,300
Self-citation
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
Self-citation
Dual-Chamber Pacing or Ventricular Backup Pacing in Patients With an Implantable Defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial
The DAVID Trial Investigators* (2002) · JAMA · doi:10.1001/jama.288.24.3115 · Cited by 2,056
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Circulation · doi:10.1161/circualtionaha.108.189742 · Cited by 1,772
Self-citation
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
Linde, C. M., Abraham, W. T., Gold, M. R., Sutton, M. S. J., Ghio, S., & Daubert, J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.027 · Cited by 1,269
Self-citation

Flagged first, then by citations

Show all 17 references

Sorted by citations

Items 501–600 of 1,002

Cardiac resynchronization therapy in ischemic and non‐ischemic cardiomyopathy
Yokoshiki, H., Mitsuyama, H., Watanabe, M., Mitsuhashi, T., & Shimizu, A. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.03.002 · Cited by 43
Implantation techniques and outcomes after cardiac resynchronization therapy for congenitally corrected transposition of the great arteries
Moore, J. P., Cho, D. J., Lin, J. P., Lluri, G., Reardon, L. C., Aboulhosn, J., Hageman, A., & Shannon, K. M. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.08.017 · Cited by 43
Non-response to Cardiac Resynchronization Therapy
Naqvi, S. Y., Jawaid, A., Goldenberg, I., & Kutyifa, V. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0407-7 · Cited by 43
Spanish Implantable Cardioverter-Defibrillator Registry. Sixth Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2009)
Alzueta, J., Linde, A., Barrera, A., Peña, J., & Peinado, R. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70281-4 · Cited by 43
The use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology
Lundqvist, C. B., Auricchio, A., Brugada, J., Boriani, G., Bremerich, J., Cabrera, J. Á., Frank, H., Gutberlet, M., Heidbüchel, H., Kück, K., et al. (2013) · EP Europace · doi:10.1093/europace/eut084 · Cited by 42
Plasma Galectin-3 and Heart Failure Outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)
Stolen, C., Adourian, A. S., Meyer, T. E., Steín, K. M., & Solomon, S. D. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.07.018 · Cited by 42
Self-citation
Management of heart failure
Krum, H., & Driscoll, A. L. (2013) · The Medical Journal of Australia · doi:10.5694/mja12.10993 · Cited by 43
Imaging for Planning of Cardiac Resynchronization Therapy
Heydari, B., Jerosch‐Herold, M., & Kwong, R. Y. K. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.11.006 · Cited by 42
Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: Differential diagnosis and prediction of cardiac outcome
Machii, M., Satoh, H., Shiraki, K., Saotome, M., Urushida, T., Katoh, H., Takehara, Y., Sakahara, H., Ohtani, H., Wakabayashi, Y., et al. (2013) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2013.10.011 · Cited by 42
Chronic Kidney Disease and Cardiac Remodelling in Patients with Mild Heart Failure: Results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) Study
Mathew, J. S., Katz, R., Sutton, M. S. J., Dixit, S., Gerstenfeld, E. P., Ghio, S., Gold, M. R., Linde, C. M., Shlipak, M. G., & Deo, R. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs135 · Cited by 42
Heart Failure Therapies for End-Stage Chemotherapy–Induced Cardiomyopathy
Mukku, R. B., Fonarow, G. C., Watson, K. E., Ajijola, O. A., DePasquale, E. C., Nsair, A., Baas, A. S., Deng, M. C.-H. K., & Yang, E. H. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.04.009 · Cited by 42
New York Heart Association Functional Class, Qrs Duration, and Survival in Heart Failure with Reduced Ejection Fraction: Implications for Cardiac Resychronization Therapy
Braunschweig, F., Linde, C. M., Benson, L., Ståhlberg, M., Dahlström, U., & Lund, L. H. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.563 · Cited by 42
Management of Heart Failure Patients with Reduced Ejection Fraction
Mann, D. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00028-7 · Cited by 42
Survival After Implantable Cardioverter-Defibrillator Shocks
Aktaş, M. K., Younis, A., Zaręba, W., Kutyifa, V., Klein, H., Daubert, J. P., Estes, M., McNitt, S. A., Polonsky, B., & Goldenberg, I. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.329 · Cited by 42
Self-citation
Pacing Characteristics of His Bundle Pacing vs. Left Bundle Branch Pacing: A Systematic Review and Meta-Analysis
Zhuo, W., Zhong, X., Liu, H., Yu, J., Chen, Q., Hu, J., Xiong, Q., & Hong, K. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.849143 · Cited by 42
Gender Differences in ECG Parameters and Their Clinical Implications
Moss, A. J. (2010) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2009.00345.x · Cited by 42
Self-citation
Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibition According to Left Ventricular Ejection Fraction in DAPA-HF
Dewan, P., Solomon, S. D., Jhund, P. S., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., DeMets, D. L., Sabatine, M. S., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1867 · Cited by 41
Self-citation
Impact of Carvedilol and Metoprolol on Inappropriate Implantable Cardioverter-Defibrillator Therapy
Ruwald, M. H., Abu-Zeitone, A., Jøns, C., Ruwald, A., McNitt, S. A., Kutyifa, V., Zaręba, W., & Moss, A. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.087 · Cited by 41
Self-citation
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
Kusumoto, F. M., Calkins, H. G., BOEHMER, J. P., Buxton, A. E., Chung, M. K., Gold, M. R., Hohnloser, S. H., Indik, J. H., Lee, R., Mehra, M. R., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.041 · Cited by 41
A Randomized Study of Haemodynamic Effects and Left Ventricular Dyssynchrony in Right Ventricular Apical vs. High Posterior Septal Pacing in Cardiac Resynchronization Therapy
Kristiansen, H. M., Vollan, G., Hovstad, T., Keilegavlen, H., & Færestrand, S. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr162 · Cited by 41
Predicting Hyperresponse Among Pacemaker‐Dependent Nonischemic Cardiomyopathy Patients Upgraded to Cardiac Resynchronization
ADELSTEIN, E. C., SCHWARTZMAN, D. S., Gorcsan, J., & Saba, S. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02018.x · Cited by 41
Enhanced cardiac PI3Kα signalling mitigates arrhythmogenic electrical remodelling in pathological hypertrophy and heart failure
Yang, K., Jay, P. Y., McMullen, J. R., & Nerbonne, J. M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr283 · Cited by 41
Physiological mechanisms of QRS narrowing in bundle branch block patients undergoing permanent His bundle pacing
Teng, A. E., Massoud, L., & Ajijola, O. A. (2016) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2016.07.013 · Cited by 41
Targeted Left Ventricular Lead Implantation Strategy for Non-Left Bundle Branch Block Patients
Singh, J. P., Berger, R. D., Doshi, R. N., Lloyd, M. S., Moore, D., Stone, J. E., & Daoud, E. G. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.04.034 · Cited by 43
Interventional heart failure therapy: A new concept fighting against heart failure
Saku, K., Yokota, S., Nishikawa, T., & Kinugawa, K. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.11.018 · Cited by 41
Virtual pacing of a patient’s digital twin to predict left ventricular reverse remodelling after cardiac resynchronization therapy
Koopsen, T., Gerrits, W., van Osta, N., van Loon, T., Wouters, P. C., Prinzen, F. W., Vernooy, K., Delhaas, T., Teske, A. J., Meine, M., et al. (2023) · EP Europace · doi:10.1093/europace/euae009 · Cited by 40
Comparison of Long-Term Survival of Men Versus Women With Heart Failure Treated With Cardiac Resynchronization Therapy
Mooyaart, E. A. Q., Marsan, N. A., van Bommel, R. J., Thijssen, J., Borleffs, C. J. W., Delgado, V., van der Wall, E. E., Schalij, M. J., & Bax, J. J. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.02.345 · Cited by 40
Usefulness of Echocardiographically Guided Left Ventricular Lead Placement for Cardiac Resynchronization Therapy in Patients With Intermediate QRS Width and Non–Left Bundle Branch Block Morphology
Marek, J. J., Saba, S., Onishi, T., Ryo, K., SCHWARTZMAN, D. S., ADELSTEIN, E. C., & Gorcsan, J. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.024 · Cited by 40
Heart Failure in Women
Taylor, A. L. (2015) · Current Heart Failure Reports · doi:10.1007/s11897-015-0252-x · Cited by 41
Cost-effectiveness of cardiac resynchronisation therapy
Boriani, G., Diemberger, I., Biffi, M., & Martignani, C. (2012) · Heart · doi:10.1136/heartjnl-2012-301845 · Cited by 40
Healthcare personnel resource burden related to in-clinic follow-up of cardiovascular implantable electronic devices: a European Heart Rhythm Association and Eucomed joint survey
Boriani, G., Auricchio, A., Klersy, C., Kirchhof, P. F., Brugada, J., Morgan, J., & Vardas, P. E. (2011) · EP Europace · doi:10.1093/europace/eur026 · Cited by 40
Defibrillators
Al‐Khatib, S. M., Friedman, P. A., & Ellenbogen, K. A. (2016) · Circulation · doi:10.1161/circulationaha.116.021889 · Cited by 40
Utility of Frailty Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy
Kubala, M., Guédon-Moreau, L., Anselme, F., Klug, D., Bertaina, G., Traullé, S., Buiciuc, O., Savouré, A., Diouf, M., & Hermida, J.-S. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.06.012 · Cited by 40
The role of interventricular conduction delay to predict clinical response with cardiac resynchronization therapy
Gold, M. R., Yu, Y., Wold, N. D., & Day, J. D. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.016 · Cited by 39
Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial
Stephansen, C., Sommer, A., Kronborg, M. B., Jensen, J. M., Nørgaard, B. L., Gerdes, C., Kristensen, J., Jensen, H. K., Fyenbo, D. B., Bouchelouche, K., et al. (2019) · EP Europace · doi:10.1093/europace/euz184 · Cited by 40
Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
Mealing, S., Woods, B. S., Hawkins, N., Cowie, M., Plummer, C., Abraham, W. T., Beshai, J. F., Klein, H., & Sculpher, M. J. (2016) · Heart · doi:10.1136/heartjnl-2015-308883 · Cited by 40
Self-citation
Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure
Singh, J. P., Rinaldi, C. A., Sanders, P., Kubo, S. H., James, S., Niazi, I. K., Betts, T. R., Butter, C., Okabe, T., Cunnane, R. T., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.2050 · Cited by 39
Long-Term Outcomes of Left Bundle-Branch Pacing vs Biventricular Pacing in Heart Failure
Chen, X., Liu, X., Li, R., Wang, Z., Liang, Y., Zhang, L., Wang, W., Bai, J., Wang, J., Qin, S., et al. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.0083 · Cited by 41
The role of AV and VV optimization for CRT
Brabham, W. W., & Gold, M. R. (2013) · Journal of Arrhythmia · doi:10.1016/j.joa.2013.02.001 · Cited by 40
Clinical Trials Update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT
Cleland, J. G. F., Coletta, A. P., Buga, L., Antony, R., Pellicori, P., Freemantle, N., & Clark, A. L. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr015 · Cited by 39
Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies
Makki, N. M., Dominic, P. S., Hanmer, J., & Olshansky, B. (2013) · EP Europace · doi:10.1093/europace/eut277 · Cited by 39
Incidence, definition, diagnosis, and management of the cardiac resynchronization therapy nonresponder
Zhang, Q., Zhou, Y., & Yu, C. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000140 · Cited by 39
Impact of age and sex on left ventricular function determined by coronary computed tomographic angiography: results from the prospective multicentre CONFIRM study
Gebhard, C., Buechel, R. R., Stähli, B. E., Gransar, H., Achenbach, S. S., Berman, D. S., Budoff, M. J., Callister, T. Q., Chow, B. J. W., Dunning, A. M., et al. (2016) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jew142 · Cited by 38
Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome
Sardu, C., Santamaria, M., Funaro, S., Sacra, C., Barbieri, M., Paolisso, P., Marfella, R., Paolisso, G., & Rizzo, M. R. (2017) · Medicine · doi:10.1097/md.0000000000006558 · Cited by 39
Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes
Sardu, C., Barbieri, M., Santamaria, M., Giordano, V., Sacra, C., Paolisso, P., Spirito, A., Marfella, R., Paolisso, G., & Rizzo, M. R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0554-2 · Cited by 39
Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis
Donnellan, E., Wazni, O. M., Hanna, M. A., Kanj, M. H., Saliba, W. I., & Jaber, W. A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017335 · Cited by 39
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis
Tini, G., Bertero, E., Signori, A., Sormani, M. P., Maack, C., de Boer, R. A., Canepa, M., & Ameri, P. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.016309 · Cited by 40
Reverse Electrical Remodeling by Cardiac Resynchronization Therapy: Prevalence and Clinical Impact
Sebag, F. A., Martins, R. P., Defaye, P., Hidden‐Lucet, F., Mabo, P., Daubert, J., & Leclercq, C. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02376.x · Cited by 39
Self-citation
Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis
Hess, P. L., Jackson, K. P., Hasselblad, V., & Al-Khatib, S. M. (2013) · Current Cardiology Reports · doi:10.1007/s11886-012-0330-6 · Cited by 38
Differences in Presentation, Diagnosis and Management of Heart Failure in Women. A Scientific Statement of the Heart Failure Association of the ESC
Rosano, G. M. C., Stolfo, D., Anderson, L., Abdelhamid, M., Adamo, M., Bauersachs, J., Bayés‐Genís, A., Böhm, M., Chioncel, O. D., Filippatos, G. S., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3284 · Cited by 48
Elimination of phrenic nerve stimulation occurring during CRT
Mehta, P. A., Shetty, A., Squirrel, M., Bostock, J., & Rinaldi, C. A. (2011) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-011-9598-5 · Cited by 38
The Future of Heart Transplantation
KOBASHIGAWA, J. A. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04223.x · Cited by 39
Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy
Upadhyay, G. A., Chatterjee, N. A., Kandala, J., Friedman, D. J., Park, M.-Y., Tabtabai, S., Hung, J., & Singh, J. P. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.02.022 · Cited by 38
Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors
Abraham, W. T. (2013) · EP Europace · doi:10.1093/europace/eut105 · Cited by 38
Current and Evolving Clinical Applications of Multidetector Cardiac CT in Assessment of Structural Heart Disease
Nasis, A., Mottram, P. M., Cameron, J. D., & SENEVIRATNE, S. K. (2013) · Radiology · doi:10.1148/radiol.13111196 · Cited by 38
Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT
Skali, H., Gerwien, R. W., Meyer, T. E., Snider, J., Solomon, S. D., & Stolen, C. (2016) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-016-9713-1 · Cited by 38
Self-citation
Prognostic Importance of Left Ventricular Mechanical Dyssynchrony in Heart Failure with Preserved Ejection Fraction
Biering‐Sørensen, T., Shah, S. J., Anand, I. S., Sweitzer, N. K., Claggett, B. L., Liu, L., Pitt, B., Pfeffer, M. A., Solomon, S. D., & Shah, A. M. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.789 · Cited by 37
Self-citation
Cardiac resynchronization is pro-arrhythmic in the absence of reverse ventricular remodelling: a systematic review and meta-analysis
Deif, B., Ballantyne, B. A., Almehmadi, F., Mikhail, M., McIntyre, W. F., Manlucu, J., Yee, R. K., Sapp, J. L., Roberts, J. D., Healey, J. S., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy182 · Cited by 38
Outcomes of conduction system pacing for cardiac resynchronization therapy in patients with heart failure: A multicenter experience
Ezzeddine, F. M., Pistiolis, S., Pujol‐López, M., Lavelle, M. T., Wan, E. Y., Patton, K. K., Robinson, M., Lador, A., Tamirisa, K. P., Karim, S., et al. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.02.018 · Cited by 38
Sex-related similarities and differences in responses to heart failure therapies
Chyou, J. Y., Qin, H., Butler, J., Voors, A. A., & Lam, C. S. P. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-00996-1 · Cited by 37
Comparative long-term outcomes after cardiac resynchronization therapy in right ventricular paced patients versus native wide left bundle branch block patients
Tayal, B., Gorcsan, J., Delgado-Montero, A., Goda, A., Ryo, K., Saba, S., Risum, N., & Søgaard, P. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.11.001 · Cited by 37
Baseline Functional Class and Therapeutic Efficacy of Common Heart Failure Interventions: A Systematic Review and Meta-analysis
Miller, R. J. H., Howlett, J. G., Exner, D. V., Campbell, P. M., Grant, A. D., & Wilton, S. B. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.12.031 · Cited by 36
Differentiation between left bundle branch block and left ventricular hypertrophy: Implications for cardiac resynchronization therapy
Strauss, D. G. (2012) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2012.09.001 · Cited by 38
Functional Response to Cardiac Resynchronization Therapy is Associated with Improved Clinical Outcome and Absence of Appropriate Shocks
van Boven, N., Bogaard, K., RUITER, J. H., Kimman, G. P., Theuns, D. A. M. J., Kardys, I., & Umans, V. A. W. M. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12037 · Cited by 37
Optimization of Cardiac Resynchronization Therapy: Importance of Programmed Parameters
Cuoco, F. A., & Gold, M. R. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02235.x · Cited by 37
Rationale and Design of the Adaptresponse Trial: A Prospective Randomized Study of Cardiac Resynchronization Therapy with Preferential Adaptive Left Ventricular-Only Pacing
Filippatos, G. S., Birnie, D. H., Gold, M. R., Gerritse, B., Hersi, A. S., Jacobs, S., KUSANO, K. F., Leclercq, C., Müllens, W., & Wilkoff, B. L. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.895 · Cited by 37
Sequential His bundle and left ventricular pacing for cardiac resynchronization
Deshmukh, A., Sattur, S., Bechtol, T., Heckman, L. I. B., Prinzen, F. W., & Deshmukh, P. M. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14674 · Cited by 37
Left Bundle Branch Block and Mortality in Patients with Acute Heart Failure Syndrome: A Substudy of the EFICA Cohort
Huvelle, E., Fay, R., Alla, F., Solal, A. C., Mebazaa, A., & Zannad, F. M. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp180 · Cited by 37
Effectiveness of Cardiac Resynchronization Therapy in Mild Congestive Heart Failure: Systematic Review and Meta-Analysis of Randomized Trials
Lubitz, S. A., Leong‐Sit, P., Fine, N. M., Kramer, D. B., Singh, J. P., & Ellinor, P. T. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq029 · Cited by 37
Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial
Lee, A. Y., Kutyifa, V., Ruwald, M. H., McNitt, S. A., Polonsky, B., Zaręba, W., Moss, A. J., & Ruwald, A. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.05.016 · Cited by 37
Self-citation
Comorbidity Significantly Affects Clinical Outcome After Cardiac Resynchronization Therapy Regardless of Ventricular Remodeling
Verbrugge, F. H., Dupont, M., Rivero‐Ayerza, M., Vusser, P. D., Herendael, H. V., Vercammen, J., Jacobs, L., Verhaert, D., Vandervoort, P. M., Tang, W. H. W., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.09.003 · Cited by 36
Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure
Gold, M. R., Padhiar, A., Mealing, S., Sidhu, M. K., Tsintzos, S. I., & Abraham, W. T. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2016.10.014 · Cited by 37
Clinical Effectiveness of CRT and ICD Therapy in Heart Failure Patients by Racial/Ethnic Classification
Ziaeian, B., Zhang, Y., Albert, N. M., Curtis, A. B., Gheorghiade, M., Heywood, J. T., Mehra, M. R., O’Connor, C. M., REYNOLDS, D. W., Walsh, M. N., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.060 · Cited by 38
Development of the Implantable Cardioverter-Defibrillator
Maron, B. J., Estes, N. A. M., Rowin, E. J., Maron, M. S., & Reynolds, M. R. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.056 · Cited by 36
Self-citation
Predictors of Death and Occurrence of Appropriate Implantable Defibrillator Therapies in Patients With Ischemic Cardiomyopathy
Ng, A. C. T., Bertini, M., Borleffs, C. J. W., Delgado, V., Boersma, E. H., Piers, S. R. D., Thijssen, J., Nucifora, G., Shanks, M., Ewe, S. H., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.07.029 · Cited by 37
Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis
Chen, S., Yin, Y., & Krucoff, M. W. (2012) · EP Europace · doi:10.1093/europace/eus168 · Cited by 36
Importance of Implantable Cardioverter‐Defibrillator Back‐Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta‐Analysis
Barra, S., Providencia, R. A., TANG, A. S. L., Heck, P. M., Virdee, M., & Agarwal, S. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002539 · Cited by 36
Long-term management of end-stage heart failure
Habal, M. V., & Garan, A. R. (2017) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2017.07.003 · Cited by 40
Effect of Cardiac Resynchronization Therapy on Exercise-Induced Pulmonary Hypertension and Right Ventricular-Arterial Coupling
Martens, P., Verbrugge, F. H., Bertrand, P. B., Verhaert, D., Vandervoort, P. M., Dupont, M., Tang, W. H. W., Janssens, S. P., & Müllens, W. (2018) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.118.007813 · Cited by 36
Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation
Röger, S., Schneider, R., Rudic, B., Liebe, V., Stach, K., Schimpf, R., Borggrefe, M. M., & Kuschyk, J. (2014) · EP Europace · doi:10.1093/europace/euu050 · Cited by 35
Integration of Implantable Device Therapy in Patients with Heart Failure. A Clinical Consensus Statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)
Müllens, W., Dauw, J., Gustafsson, F., Mebazaa, A., Steffel, J., Witte, K. K., Delgado, V., Linde, C. M., Vernooy, K., Anker, S. D., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3150 · Cited by 35
Effect on Cardiac Function of Cardiac Resynchronization Therapy in Patients With Right Bundle Branch Block (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT] Trial)
TOMPKINS, C. M., Kutyifa, V., McNitt, S. A., Polonsky, B., Klein, H., Moss, A. J., & Zaręba, W. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.04.016 · Cited by 35
Self-citation
The Speckle Tracking Imaging for the Assessment of Cardiac Resynchronization Therapy (START) Study
Maruo, T., Seo, Y., Yamada, S., Arita, T., Ishizu, T., Shiga, T., Dohi, K., Toide, H., Furugen, A., Inoue, K., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0842 · Cited by 35
Extracting Versus Abandoning Sterile Pacemaker and Defibrillator Leads
Rijal, S., Shah, R. U., & Saba, S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.537 · Cited by 35
Impact of Ejection Fraction on the Clinical Response to Cardiac Resynchronization Therapy in Mild Heart Failure
Linde, C. M., Daubert, J., Abraham, W. T., Sutton, M. S. J., Ghio, S., Hassager, C., Herre, J. M., Bergemann, T. L., & Gold, M. R. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000326 · Cited by 35
Self-citation
Biventricular pacing: current trends and future strategies
Singh, J. P., & Gras, D. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr366 · Cited by 35
Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial
Sutton, M. S. J., Plappert, T. J., Adamson, P. B., Li, P., Christman, S. A., Chung, E. S., & Curtis, A. B. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001626 · Cited by 35
Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction
Gierula, J., Cubbon, R. M., Jamil, H. A., Byrom, R. J., Baxter, P. D., Pavitt, S. H., Gilthorpe, M. S., Hewison, J., Kearney, M. T., & Witte, K. K. (2013) · EP Europace · doi:10.1093/europace/eut148 · Cited by 34
Left ventricular lead stabilization to retain cardiac resynchronization therapy at long term: when is it advisable?
Biffi, M., Bertini, M., Ziacchi, M., Diemberger, I., Martignani, C., & Boriani, G. (2013) · EP Europace · doi:10.1093/europace/eut300 · Cited by 35
Imaging left‐ventricular mechanical activation in heart failure patients using cine DENSE MRI: Validation and implications for cardiac resynchronization therapy
Auger, D. A., Bilchick, K. C., Gonzalez, J. A., Cui, S., Holmes, J. W., Kramer, C. M., Salerno, M., & Epstein, F. H. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25613 · Cited by 35
Impact of Cardiac Resynchronization Therapy on Heart Transplant-Free Survival in Pediatric and Congenital Heart Disease Patients
Chubb, H., Rosenthal, D. N., Almond, C. S. D., Ceresnak, S. R., Motonaga, K. S., Arunamata, A. A., Long, J., Trela, A. V., Hanisch, D., McElhinney, D. B., et al. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007925 · Cited by 35
Sex-related differences in patients' responses to heart failure therapy
Barsheshet, A., brenyo, A. J., Goldenberg, I., & Moss, A. J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.10 · Cited by 35
Self-citation
Treatment options in end-stage heart failure: where to go from here?
Haeck, M. L. A., Hoogslag, G. E., Rodrigo, S. F., Atsma, D. E., Klautz, R. J. M., van der Wall, E. E., Schalij, M. J., & Verwey, H. F. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-011-0211-4 · Cited by 35
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms
Vizzardi, E., Nodari, S., Caretta, G., D’Aloia, A., Pezzali, N., Faden, G., Lombardi, C., Raddino, R., Metra, M., & Cas, L. D. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31829dd6b1 · Cited by 36
Predictive factors of difficult implantation procedure in cardiac resynchronization therapy
Bisch, L., Costa, A. D., Dauphinot, V., Romeyer-Bouchard, C., Khris, L., M'Baye, A., & Isaaz, K. (2010) · EP Europace · doi:10.1093/europace/euq146 · Cited by 35
Frequency of Inappropriate Therapy in Patients Implanted with Dual‐ Versus Single‐Chamber ICD Devices in the ICD Arm of MADIT‐CRT
Ruwald, A., Sood, N. A., Ruwald, M. H., Jøns, C., Clyne, C. A., McNitt, S. A., Wang, P. J., Zaręba, W., & Moss, A. J. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12099 · Cited by 34
Self-citation
Guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012
McMurray, J. J. V., Adamopoulos, S. N., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G. S., Fonseca, C., Sánchez, M. Á. G., et al. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.08.003 · Cited by 36
Improvement effect on endothelial function in patients with congestive heart failure treated with cardiac resynchronization therapy
Enomoto, K., Yamabe, H., Toyama, K., Matsuzawa, Y., Yamamuro, M., Uemura, T., Morihisa, K., Iwashita, S., Kaikita, K., Sugiyama, S., et al. (2011) · Journal of Cardiology · doi:10.1016/j.jjcc.2011.01.010 · Cited by 34
Validation of Seattle Heart Failure Model for Mortality Risk Prediction in Patients Treated with Cardiac Resynchronization Therapy
Regoli, F. D., Scopigni, F. R., Leyva, F., Landolina, M., Ghio, S., Tritto, M. V., Calò, L., Klersy, C., Auricchio, A., & for the collaborative study group (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs162 · Cited by 34
Individually tailored left ventricular lead placement: lessons from multimodality integration between three-dimensional echocardiography and coronary sinus angiogram
Döring, M., Braunschweig, F., Eitel, C., Gaspar, T., Wetzel, U., Nitsche, B., Hindricks, G., & Piorkowski, C. (2013) · EP Europace · doi:10.1093/europace/eus396 · Cited by 34

Authors: Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. M., Foster, E., Greenberg, H., Higgins, S. L., Pfeffer, M. A., Solomon, S. D., Wilber, D., & Zareba, W.
Affiliations: University of Rochester Medicine (US)
Good Samaritan Hospital (US)
Duke Medical Center (US)
University of California, San Francisco (US)
St. Luke's-Roosevelt Hospital Center (US)
Scripps Memorial Hospital (US)
Brigham and Women's Hospital (US)
Loyola University Medical Center (US)
ORCID: Moss, Arthur J.
Hall, W. Jackson
Cannom, David S.
Klein, Helmut
Daubert, James P.
Greenberg, Henry
Pfeffer, Marc A.
Solomon, Scott D.
Wilber, David
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2009-10
Volume: 361
Issue: 14
Pages: 1329-1338
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa0906431
OpenAlex: W2146521529
Cited by: 3,157
References: 17
Citations by year: 2026: 106 · 2025: 116 · 2024: 137 · 2023: 188 · 2022: 140 · 2021: 155 · 2020: 163 · 2019: 173 · 2018: 174 · 2017: 199 · 2016: 210 · 2015: 210 · 2014: 227 · 2013: 243 · 2012: 267
FWCI: 151.00
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: cardiac resynchronization therapy, implantable cardioverter-defibrillator, heart failure prevention, reduced ejection fraction, wide QRS complex, ischemic cardiomyopathy, non-ischemic cardiomyopathy, left ventricular volume, ejection fraction, mortality, asymptomatic patients
MeSH terms: Aged, Cardiac Pacing, Artificial, Electric Countershock, Female, Heart Failure, Humans, Male, Middle Aged, Pacemaker, Artificial, Stroke Volume, Defibrillators, Implantable, Disease-Free Survival, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks